Offerings // PROVECTUS BIOPHARMACEUTICALS, INC.

PVCT offering history

Every offering-related filing in PROVECTUS BIOPHARMACEUTICALS, INC.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,000 filings back to Jun 29, 2004.

Last executed offering

Jan 22, 2025

8-K — priced deal (shares or notes)

Last registration (announced)

Jan 26, 2017

S-1/A — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Jan 22, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jul 17, 2024	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Sep 26, 2022	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Aug 18, 2021	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jun 24, 2021	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Mar 6, 2017	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Feb 21, 2017	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Feb 9, 2017	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jan 31, 2017	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Jan 27, 2017	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jan 26, 2017	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jan 19, 2017	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Dec 21, 2016	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Dec 6, 2016	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Nov 22, 2016	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Nov 1, 2016	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Oct 5, 2016	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Aug 26, 2016	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 24, 2016	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 1, 2016	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
May 27, 2016	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 11, 2016	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 7, 2016	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jan 20, 2016	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jan 15, 2016	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jan 14, 2016	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Jul 27, 2015	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jul 16, 2015	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jun 19, 2015	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 19, 2015	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jun 19, 2015	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 2, 2015	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
May 8, 2014	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Apr 30, 2014	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Apr 30, 2014	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 12, 2013	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Sep 26, 2013	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Aug 8, 2013	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jul 26, 2013	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 10, 2013	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital

PVCT offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full PVCT workspace →

PVCT offering FAQ

When did PVCT last execute an offering?

Per SEC filings, PROVECTUS BIOPHARMACEUTICALS, INC.'s most recent priced offering document is a 8-K filed 2025-01-22. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did PVCT last announce or register an offering?

The most recent registration is a S-1/A filed 2017-01-26. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.